GRK2-Targeted Knockdown as Therapy for Multiple System Atrophy.
Miguel Lopez-CuinaPaul GuérinNathalie DutheilChristelle MartinThierry Leste LasserrePierre Olivier FernagutWassillios G MeissnerErwan BezardPublished in: Movement disorders : official journal of the Movement Disorder Society (2023)
These data support GRK2 as a potential therapeutic target in MSA. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.